Back to search results

CorEvitas International Adolescent Atopic Dermatitis Drug Safety and Effectiveness Registry

This is an observational study for adolescents with moderate to severe atopic dermatitis (eczema). It's called a registry, which means researchers will collect information about your condition and the treatments you receive over time. The goal is to better understand how atopic dermatitis affects young people and how well different treatments work and if they have any side effects. You can join if you are between 10 and 15 years old and have been diagnosed with moderate to severe atopic dermatitis by a skin doctor. This study is currently recruiting about 1500 participants across North America and some European countries.

Study design
This is an observational registry study, meaning researchers will collect information about your health and treatments without giving you a specific intervention. Approximately 1500 participants will be included.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed until they turn 18 years old.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06238765

CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry

Recruiting
Not specifiedAges 10–15Observational
CorEvitas
~1,500 participants
Updated 2026-06-29 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
AD epidemiology, presentation, natural history, management, and outcomes
Measured over Through Study completion until the subject is 18 years

Conditions

Atopic Dermatitis

Explore related trials

Atopic Dermatitis

Where it's being run

1 sites across 1 states
Massachusetts1

Who to contact

Cathy Cheney
[email protected]
508-555-1212
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

To be eligible to participate in this registry, an individual must meet all the following criteria:

Exclusion

An individual who meets any of the following criteria will be excluded from participation in the registry:

What this trial measures

  • AD epidemiology, presentation, natural history, management, and outcomesThrough Study completion until the subject is 18 years

    The major clinical outcomes include an assessment of the epidemiology of Atopic Dermatitis; to better understand the presentation, natural history, management and outcomes.